Immunochemical, serologic, and immunologic properties of major antigens isolated from the Legionnaires' disease bacterium. Observations bearing on the feasibility of a vaccine
- PMID: 86314
- DOI: 10.7326/0003-4819-90-4-634
Immunochemical, serologic, and immunologic properties of major antigens isolated from the Legionnaires' disease bacterium. Observations bearing on the feasibility of a vaccine
Abstract
Two antigens were isolated from each of three strains of the Legionnaires' disease (LD) bacterium. One antigen was serotype-specific; the other cross-reacted with strains of LD bacteria of different serotypes. The serotypic antigens contained all the major branched-chain fatty acids characteristic of LD bacteria and were a lipid-protein-carbohydrate complex. Electrophoresis resolved the serotypic antigen of Knoxville 1 strain into four protein bands and one glycoprotein band with molecular weights ranging from 0.5 to 7.2 x 10(5). The specificity of the serotypic antigens was established by immunofluorescent staining, and double gel diffusion confirmed the absence of cross-reactions between the serotypic antigens of different types and the partial identity of the serotypic antigens from serologically related strains. The cross-reacting antigens formed precipitin bands with all the homologous and heterologous sera tested. Induction of immunity by vaccination with serotypic antigens was shown in three animal models using guinea pigs and mice. Passive-transfer of immunity (IgG) was also shown in mice and guinea pigs. These observations raise the possiblity of a vaccine for protection against infection of LD bacteria.
Similar articles
-
A high molecular weight antigen in Legionnaires' disease bacterium: isolation and partial characterization.Ann Intern Med. 1979 Apr;90(4):638-41. doi: 10.7326/0003-4819-90-4-638. Ann Intern Med. 1979. PMID: 434650
-
Vaccination with the major secretory protein of Legionella pneumophila induces cell-mediated and protective immunity in a guinea pig model of Legionnaires' disease.J Exp Med. 1989 Mar 1;169(3):691-705. doi: 10.1084/jem.169.3.691. J Exp Med. 1989. PMID: 2926324 Free PMC article.
-
Immunologic factors affecting the in-vivo and in-vitro survival of the Legionnaires' disease bacterium.Ann Intern Med. 1979 Apr;90(4):680-3. doi: 10.7326/0003-4819-90-4-680. Ann Intern Med. 1979. PMID: 373551
-
[Legionnaires' disease. Immunity and immunosuppression].Nouv Rev Fr Hematol (1978). 1982;24(5):321-33. Nouv Rev Fr Hematol (1978). 1982. PMID: 6762525 Review. French. No abstract available.
-
Mouse models of Legionnaires' disease.Curr Top Microbiol Immunol. 2013;376:271-91. doi: 10.1007/82_2013_349. Curr Top Microbiol Immunol. 2013. PMID: 23918179 Review.
Cited by
-
Antigenic specificity of the antibody response in humans during legionellosis.Infection. 1986 May-Jun;14(3):108-14. doi: 10.1007/BF01643473. Infection. 1986. PMID: 2426202
-
Simple, transparent medium for study of legionellae.J Clin Microbiol. 1982 Feb;15(2):342-4. doi: 10.1128/jcm.15.2.342-344.1982. J Clin Microbiol. 1982. PMID: 7068831 Free PMC article.
-
Bacterial antigen detection in body fluids: methods for rapid antigen concentration and reduction of nonspecific reactions.J Clin Microbiol. 1980 Apr;11(4):380-4. doi: 10.1128/jcm.11.4.380-384.1980. J Clin Microbiol. 1980. PMID: 7372801 Free PMC article.
-
The diagnosis of Legionnaires' disease by counterimmunoelectrophoresis.J Clin Pathol. 1980 Dec;33(12):1174-8. doi: 10.1136/jcp.33.12.1174. J Clin Pathol. 1980. PMID: 7005268 Free PMC article.
-
Background prevalence of microagglutination antibodies to Legionella pneumophila serogroups 1, 2, 3, and 4.Infect Immun. 1980 Nov;30(2):612-4. doi: 10.1128/iai.30.2.612-614.1980. Infect Immun. 1980. PMID: 7439997 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials